Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on X:
“SBRT and liver transplant in previously untreated unresectable HCC.
SBRT may be used as a bridging treatment while waiting for deceased donor liver transplant.
PET-CT and MRI with contrast may be used for response evaluation.”
Proceed to the article.
Source: Erman Akkus/X
